Prevention and Treatment of Genital Viral Infections during Intimate Plastic Surgery
https://doi.org/10.31550/1727-2378-2024-23-5-73-78
Abstract
Aim. Consider an optimized comprehensive approach to the treatment of genital herpetic infection against the background of intimate plastic surgery.
Key points. Even when using high-quality volume-forming preparations based on hyaluronic acid, if all norms and rules are followed, possible complications include re-activation of herpes virus infection. Properly selected antiviral and immunomodulatory drugs provide postprocedural care to prevent reactivation of the herpes simplex virus and effective and safe treatment in case of exacerbation of the disease after injection of fillers.
Conclusion. Prompt prevention of re-activation and therapy, where required, of virus infections. as exemplified by herpes virus infection, allows reducing the risk of recurrence after intimate plasty and making the procedure compliant with patients' expectations.
About the Authors
T. V. Tazina
ФГБОУ ВО «Рязанский государственный медицинский университет имени академика И.П. Павлова» Минздрава России
Russian Federation
Russian Federation
T. N. Bebneva
Peoples' Friendship University of Russia named after Patrice Lumumba; Endocrinology Research Center
Russian Federation
Russian Federation
21 Miklukho-Maklaya Str., corpus 3, Moscow, 117198
11 Dm. Ulyanova Str., Moscow, 117292
References
1. Protsenko AS, Abishev RE. Modern trends in assessment of efficiency of medical care using quality of life criteria. In: Proceedings of the International Scientific and Practical Conference "Modern healthcare: development trends" Novosibirsk: SibAK; 2012: 92–5.
2. Potemina T.E., Kuznetsova S.V., Pereshein A.V., Samoilova O.Yu. et al. Quality of life in healthcare services: criteria, goals, prospects. Russian Osteopathic Journal. 2018;3– 4:98–106. (in Russian). DOI: 10.32885/2220-0975-2018-3-4-98-106
3. Sokolova A.V., Apolikhina I.A. Hyaluronic acid: prospective use in gynaecology. Doctor.Ru. 2021;20(8):36–40. (in Russian). DOI: 10.31550/1727-2378-2021-20-8-36-40
4. Kazakova S.N., Apolikhina I.A., Teterina T.A., Pauzina O.A. Modern approach to therapy of vaginal relaxation syndrome. Medical Opponent. 2020;2(10):58–64. (in Russian)
5. Sirotina L.Z., Motovilova T.M., Trifonova O.Yu., Kruglova I.A. et al. Current understanding of genitourinary syndrome of menopause (review). Medical Almanac. 2024;1(78):15–27. (in Russian)
6. Huang G., Chen J. Preparation and applications of hyaluronic acid and its derivatives. Int. J. Biol. Macromol. 2019;125:478–84. DOI: 10.1016/j.ijbiomac.2018.12.074
7. Cohen J.L. Understanding, avoiding, and managing dermal filler complications. Dermatol. Surg. 2008;34(suppl.1):S92–9. DOI: 10.1111/j.1524-4725.2008.34249.x
8. Kruglova L.S., Gres S.N. Antiviral therapy in prevention of complications of cosmetic procedures. Medical Alphabet. 2022;1(27):61–6. (in Russian). DOI: 10.33667/2078-5631-2022-27-61-66
9. Geretti A.M., Brown D.W. National survey of diagnostic services for genital herpes. Sex Transm. Infect. 2005;81(4):316–17. DOI: 10.1136/sti.2004.013110
10. Khaitov R.M., Ataullakhanov R.I., eds. Immunotherapy. M.: GEPTAR-Media; 2011. 672 p. (in Russian)
11. Dougherty A.L., Rashid R.M., Bangert C.A. Angioedema-type swelling and herpes simplex virus reactivation following hyaluronic acid injection for lip augmentation. J. Am. Acad. Dermatol. 2011;65(1):e21–2. DOI: 10.1016/j.jaad.2010.11.043
12. Gazzola R., Pasini L., Cavallini M. Herpes virus outbreaks after dermal hyaluronic acid filler injections. Aesthet. Surg. J. 2012;32(6):770–2. DOI: 10.1177/1090820X12452293
13. Khoo C.S., Tan H.J., Sharis Osman S. A case of herpes simplex virus type 1 (HSV-1) encephalitis as a possible complication of cosmetic nasal dermal filler injection. Am. J. Case Rep. 2018;19:825–8. DOI: 10.12659/AJCR.909883
14. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm. Infect. 2002;78(3):160–5. DOI: 10.1136/sti.78.3.160
15. Wald A., Huang M.-L., Carrell D., Selke S. et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J. Infect. Dis. 2003;188(9):1345–51. DOI: 10.1086/379043
16. Isakov V.A., Arhipova E.I., Isakov D.V. Herpesviral infections in human: guidelines for physicians. SPb.: SpecLit; 2013. 670 p. (in Russian)
17. Takaoka A., Hayakawa S., Yanai H., Stoiber D. et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature. 2003;424(6948): 16–523. DOI: 10.1038/nature01850
18. Moiseeva O., Mallette F.A., Mukhopadhyay U.K., Moores A. et al. DNA damage signaling and p53-dependent senescence after prolonged -interferon stimulation. Mol. Biol. Cell. 2006;17(4):1583–92. DOI: 10.1091/mbc.e05-09-0858
19. Fensterl V., Sen G.C. Interferons and viral infections. Biofactors. 2009;35(1):14–20. DOI: 10.1002/biof.6
20. de Veer M.J., Holko M., Frevel M., Walker E. et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001;69(6):912–20.
21. Vavilenkova Yu.A. Modern conception of interferon system. Vestnik of the Smolensk Medical State Academy. 2012;11(2):12–82. (in Russian)
22. Khryanin A.A., Knorring G.Yu., Sokolovskaya A.V. Interferon therapy of recurrent herpesvirus infections. Russian Journal of Clinical Dermatology and Venereology. 2022;21(2):214–19. (in Russian). DOI: 10.17116/klinderma202221021214
23. Khaldin А.А., Samgin М.A., Baskakova D.V., Vasilyev A.N. Local therapy for herpes simplex: PRO and CONTRA. Russian Journal of Skin and Venereal Diseases. 2007;S2:1–10. (in Russian)
24. Lobov A.V., Pogodina E.A., Ivanova P.I., Ugarova N.V. et al. Human interferon status. Standardization of the tests and establishing reference values. Russian Journal of Biotherapy. 2022;21(4): 30–40. (in Russian). DOI: 10.17650/1726-9784-2022-21-4-30-40
25. Moskalev A.V., Gumilevskiy B.Yu. Modern idea of the role of the interferon system in the development of innate virus-induced immunity mechanisms. In: Open issues of causal treatment of current infections. SPb; 2022:113–21. (in Russian)
26. Stovbun S.V., Kalinina T.S., Zlenko D.V., Kiselev A.V. et al. Antiviral potential of plant polysaccharide nanoparticles actuating nonspecific immunity. Int. J. Biol. Macromol. 2021:182:743–9. DOI: 10.1016/j.ijbiomac.2021.03.135
27. Karakhalis L.Yu., Penzhoian G.A., Ponomarev V.V., Stovbun S.V. et al. Antirecurrent therapy for herpesvirus type 2 infection. Russian Bulletin of Obstetrician-Gynecologist. 2017;17(4):84–7. (in Russian). DOI: 10.17116/rosakush201717484-87
28. Martinez M.J.A., Olmo L.M.B.D., Benito P.B. Antiviral activities of polysaccharides from natural sources. Stud. Nat. Prod. Chem. 2005;30:393–418.
29. Wang W., Wang S.-X., Guan H.-S. The antiviral activities and mechanisms of marine polysaccharides: an overview. Mar. Drugs. 2012;10(12):2795–816. DOI: 10.3390/md10122795
30. Chen L., Huang G. The antiviral activity of polysaccharides and their derivatives. Int. J. Biol. Macromol. 2018;115:77–82. DOI: 10.1016/j.ijbiomac.2018.04.056
31. Melnikova S.E., Stovbun S.V., Korobkova E.V., Kiselev A.V. et al. Efficacy of Panavir in patients with recurrent genital herpes. Russian Bulletin of Obstetrician-Gynecologist. 2017;17(3):97–101. (in Russuan). DOI: 10.17116/rosakush201717397-101
32. Maliy V.P., ed. Herpesvirus infection. М.; 2009. 304 p. (in Russian)
33. Chernova N.I., Zadorozhnaya I.S., Kiselev A.V., Bagaeva M.I. The place of intimate hygiene products based on Solanum tuberosum polysaccharides, ammonium glycyrrhizinate and lactic acid in patients with vulvar and vaginal microbiocenosis desorders. Russian Journal of Clinical Dermatology and Venereology. 2021;20(3):34–40. (in Russian). DOI: 10.17116/klinderma20212003134
34. Ananthapadmanabhan K.P., Subramanyan K., Nole G. A global perspective on caring for healthy stratum corneum by mitigating the effects of daily cleansing: report from an expert dermatology symposium. Br. J. Dermatol. 2013:168(suppl.1):1–9. DOI: 10.1111/bjd.12087
Review
For citations:
Tazina T.V., Bebneva T.N. Prevention and Treatment of Genital Viral Infections during Intimate Plastic Surgery. Title. 2024;23(5):74-78. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-5-73-78
Views:
11
Email this article 